CannabisRadio.com, a leading podcast network previously centered on cannabis, has broadened its scope to encompass mental health, wellness, and longevity, introducing a new podcast titled 'Psychedelic Breakthrough Addiction Therapy.' Hosted by Deborah Mash, PhD, a distinguished neuroscientist, the bi-weekly show aims to illuminate the latest in addiction therapy research, particularly focusing on psychedelic medicines and alternative treatments.
Brandy Shapiro-Babin, President of CannabisRadio.com, emphasized the importance of disseminating accurate information to prevent harm and empower listeners. The podcast's inaugural episodes will concentrate on Ibogaine, a psychoactive compound from the Iboga plant, noted for its potential in treating various addictions. Mash, with her profound expertise in addiction neuroscience, will guide listeners through the complexities and promises of psychedelic therapy.
Mash's background includes pioneering research on Ibogaine and its metabolite, noribogaine, contributing significantly to the understanding of addiction treatments. Her work at DemeRx, a clinical-stage biotech company, focuses on developing non-addictive solutions for alcohol and opioid use disorders, highlighting the practical applications of her research.
The podcast represents a significant step in demystifying psychedelic therapies and their role in addressing addiction, offering hope and education to those affected. CannabisRadio.com continues to serve as a vital resource for insights into cannabis, hemp/CBD, and now psychedelics, fostering informed discussions on these evolving industries.
